• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关节积血后,接受重组FVIII或FVIII-Fc融合蛋白治疗的FVIII缺陷小鼠的滑膜基因表达存在差异。

Synovial Gene expression after Hemarthrosis differs between FVIII-deficient mice treated with recombinant FVIII or FVIII-Fc Fusion Protein.

作者信息

Chumappumkal Joseph Bilgimol, Whisenant Thomas C, Cooke Esther J, Zhou Jenny Y, Falah Nicca, De-Pablo Moreno Juan Andres, von Drygalski Annette

机构信息

Department of Medicine, Division of Hematology/Oncology, University of California San Diego, La Jolla, California, United States of America.

University of California San Diego, Center for Computational Biology and Bioinformatics, La Jolla, California, United States of America.

出版信息

PLoS One. 2025 May 19;20(5):e0320322. doi: 10.1371/journal.pone.0320322. eCollection 2025.

DOI:10.1371/journal.pone.0320322
PMID:40388523
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12088034/
Abstract

To investigate if FVIII-Fc Fusion protein (FcFVIII) may modulate inflammation and immune stimulation in hemophilic synovium via the Fc-portion of immunoglobulin used for half-life extension we performed gene expression profiling in FVIII-deficient mice. Hemarthrosis was induced by sub-patellar puncture in FVIII-KO mice, + /- periprocedural recombinant human (rh)FVIII,murine (m)FcFVIII, or mIgG2a. Synovium was harvested at baseline and on days (D) 3 and 14, followed by RNA extraction and sequencing, and histological analysis. RNASeq data were processed using standard protocols followed by differential gene expression (DGE) analysis. Functional enrichment analysis generated molecular pathways (KEGG and Reactome). To distinguish between on-target and off-target (related and unrelated to injury/bleed) effects the following groups were compared: i) Baseline vs. injured-saline, ii) injured-saline vs. injured-rhFVIII, iii) injured-saline vs. injured-mFcFVIII. Knee injury in FVIII-KO mice resulted in hemarthrosis, which was prevented by peri-procedural rhFVIII and mFcFVIII treatments. Only a small proportion of genes was affected by FVIII treatment, exhibiting overlap but also distinct differences between both FVIII-preparations. Acutely (D3), mFcFVIII had unique on-target effects related to immune and inflammatory regulation, whereas rhFVIII mostly affected mRNA and protein processing. On day 14, macrophage profiling indicated a transition from M1 to M2, and only mFcFVIII uniquely influenced pathways and genes associated with tissue remodeling and repair. Some mFcFVIII DGE patterns resembled mIgG2a patterns. Synovial vascular remodeling and cartilage health were better with mFcFVIII than rhFVIII. Interestingly, both FVIII-preparations exerted off-target effects on immune system pathways, albeit with temporal differences. These observations provide proof-of-principle that the type of FVIII preparation can influence synovial processes beyond acute hemostasis control, deserving exploration in the setting of joint bleed control in hemophilia.

摘要

为了研究FVIII-Fc融合蛋白(FcFVIII)是否可通过用于延长半衰期的免疫球蛋白的Fc部分来调节血友病性滑膜炎中的炎症和免疫刺激,我们在FVIII缺陷小鼠中进行了基因表达谱分析。通过在FVIII基因敲除(KO)小鼠的髌下穿刺诱导关节积血,手术过程中分别给予或不给予重组人(rh)FVIII、鼠源(m)FcFVIII或mIgG2a。在基线以及第3天和第14天采集滑膜,随后进行RNA提取和测序以及组织学分析。RNA测序(RNASeq)数据使用标准方案进行处理,随后进行差异基因表达(DGE)分析。功能富集分析生成分子途径(京都基因与基因组百科全书(KEGG)和Reactome)。为了区分靶向和非靶向(与损伤/出血相关和不相关)效应,比较了以下几组:i)基线与损伤-生理盐水组,ii)损伤-生理盐水组与损伤-rhFVIII组,iii)损伤-生理盐水组与损伤-mFcFVIII组。FVIII-KO小鼠的膝关节损伤导致关节积血,手术过程中给予rhFVIII和mFcFVIII治疗可预防。只有一小部分基因受FVIII治疗影响,两种FVIII制剂之间表现出重叠但也有明显差异。在急性期(第3天),mFcFVIII具有与免疫和炎症调节相关的独特靶向效应,而rhFVIII主要影响mRNA和蛋白质加工。在第14天,巨噬细胞分析表明从M1型向M2型转变,并且只有mFcFVIII独特地影响与组织重塑和修复相关的途径和基因。一些mFcFVIII的DGE模式类似于mIgG2a模式。mFcFVIII对滑膜血管重塑和软骨健康的改善优于rhFVIII。有趣的是,两种FVIII制剂均对免疫系统途径产生非靶向效应,尽管存在时间差异。这些观察结果提供了原理证明,即FVIII制剂的类型可以影响急性止血控制之外的滑膜过程,在血友病关节出血控制的背景下值得探索。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c921/12088034/71f1c662c9b3/pone.0320322.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c921/12088034/d60120262f40/pone.0320322.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c921/12088034/0d49e5c65825/pone.0320322.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c921/12088034/8c0cda62a7f5/pone.0320322.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c921/12088034/b29a579ac1a5/pone.0320322.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c921/12088034/95360bfcab8e/pone.0320322.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c921/12088034/71f1c662c9b3/pone.0320322.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c921/12088034/d60120262f40/pone.0320322.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c921/12088034/0d49e5c65825/pone.0320322.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c921/12088034/8c0cda62a7f5/pone.0320322.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c921/12088034/b29a579ac1a5/pone.0320322.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c921/12088034/95360bfcab8e/pone.0320322.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c921/12088034/71f1c662c9b3/pone.0320322.g006.jpg

相似文献

1
Synovial Gene expression after Hemarthrosis differs between FVIII-deficient mice treated with recombinant FVIII or FVIII-Fc Fusion Protein.关节积血后,接受重组FVIII或FVIII-Fc融合蛋白治疗的FVIII缺陷小鼠的滑膜基因表达存在差异。
PLoS One. 2025 May 19;20(5):e0320322. doi: 10.1371/journal.pone.0320322. eCollection 2025.
2
Defective Lymphangiogenesis and Iron Removal after Hemarthrosis in FVIII-deficient Mice are Rectified with Therapeutic FVIII Administration - Implications for Joint Health.FVIII 缺陷小鼠关节积血后淋巴管生成缺陷和铁清除障碍可通过给予治疗性 FVIII 得到纠正——对关节健康的意义。
J Thromb Haemost. 2025 Sep 2. doi: 10.1016/j.jtha.2025.08.016.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Mechanisms of vascular permeability and remodeling associated with hemarthrosis in factor VIII-deficient mice.与因子 VIII 缺乏症小鼠关节积血相关的血管通透性和重塑的机制。
J Thromb Haemost. 2019 Nov;17(11):1815-1826. doi: 10.1111/jth.14567. Epub 2019 Aug 9.
5
Clotting factor concentrates for preventing bleeding and bleeding-related complications in previously treated individuals with haemophilia A or B.用于预防既往接受过治疗的 A 型或 B 型血友病患者出血和出血相关并发症的凝血因子浓缩物。
Cochrane Database Syst Rev. 2021 Aug 18;8(8):CD014201. doi: 10.1002/14651858.CD014201.
6
Efanesoctocog Alfa versus Standard and Extended Half-Life Factor VIII Prophylaxis in Adolescent and Adult Patients with Haemophilia A without Inhibitors.依费奈索托考格阿尔法与标准及延长半衰期因子VIII预防治疗对无抑制物的青少年和成年甲型血友病患者的疗效比较
Adv Ther. 2025 Jan;42(1):427-441. doi: 10.1007/s12325-024-03032-3. Epub 2024 Nov 22.
7
Elbow Fractures Overview肘部骨折概述
8
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
9
Clotting factor concentrates for preventing bleeding and bleeding-related complications in previously untreated or minimally treated children with hemophilia A or B.用于预防既往未治疗或治疗极少的甲型或乙型血友病儿童出血及出血相关并发症的凝血因子浓缩物。
Cochrane Database Syst Rev. 2025 Aug 21;8(8):CD003429. doi: 10.1002/14651858.CD003429.pub5.
10
Human Infrapatellar Fat Pad Mesenchymal Stem Cell-derived Extracellular Vesicles Purified by Anion Exchange Chromatography Suppress Osteoarthritis Progression in a Mouse Model.阴离子交换层析法纯化的人髌下脂肪垫间充质干细胞来源细胞外囊泡抑制骨关节炎在小鼠模型中的进展。
Clin Orthop Relat Res. 2024 Jul 1;482(7):1246-1262. doi: 10.1097/CORR.0000000000003067. Epub 2024 Apr 19.

引用本文的文献

1
Correction: Synovial gene expression after hemarthrosis differs between FVIII-deficient mice treated with recombinant FVIII or FVIII-Fc fusion protein.更正:重组FVIII或FVIII-Fc融合蛋白治疗的FVIII缺陷小鼠关节积血后的滑膜基因表达存在差异。
PLoS One. 2025 Sep 4;20(9):e0331108. doi: 10.1371/journal.pone.0331108. eCollection 2025.

本文引用的文献

1
Nonfactor Therapies for Hemophilia.血友病的非凝血因子治疗方法
Hemasphere. 2023 Jun 6;7(6):e911. doi: 10.1097/HS9.0000000000000911. eCollection 2023 Jun.
2
Maladaptive lymphangiogenesis is associated with synovial iron accumulation and delayed clearance in factor VIII-deficient mice after induced hemarthrosis.适应性淋巴血管生成与因子 VIII 缺乏症小鼠诱导性关节积血后滑膜铁积累和清除延迟有关。
J Thromb Haemost. 2023 Sep;21(9):2390-2404. doi: 10.1016/j.jtha.2023.04.022. Epub 2023 Apr 26.
3
Recombinant factor VIII Fc fusion protein for first-time immune tolerance induction: final results of the verITI-8 study.
用于首次免疫耐受诱导的重组因子 VIII Fc 融合蛋白:verITI-8 研究的最终结果。
Blood. 2023 Apr 20;141(16):1982-1989. doi: 10.1182/blood.2022017780.
4
Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A.依因子VIII预防严重A型血友病患者
N Engl J Med. 2023 Jan 26;388(4):310-318. doi: 10.1056/NEJMoa2209226.
5
Influence of N-glycosylation in the A and C domains on the immunogenicity of factor VIII.A和C结构域中N-糖基化对凝血因子VIII免疫原性的影响。
Blood Adv. 2022 Jul 26;6(14):4271-4282. doi: 10.1182/bloodadvances.2021005758.
6
Hemophilic arthropathy: Current knowledge and future perspectives.血友病性关节病:现状与未来展望。
J Thromb Haemost. 2021 Sep;19(9):2112-2121. doi: 10.1111/jth.15444. Epub 2021 Jul 27.
7
Blood coagulation factor VIII D1241E polymorphism leads to a weak malectin interaction and reduction of factor VIII posttranslational modification and secretion.凝血因子VIII D1241E多态性导致与麦芽凝集素的相互作用减弱,并降低凝血因子VIII的翻译后修饰和分泌。
Exp Cell Res. 2020 Dec 1;397(1):112334. doi: 10.1016/j.yexcr.2020.112334. Epub 2020 Nov 2.
8
WFH Guidelines for the Management of Hemophilia, 3rd edition.《血友病管理的居家指南》第三版
Haemophilia. 2020 Aug;26 Suppl 6:1-158. doi: 10.1111/hae.14046. Epub 2020 Aug 3.
9
Functional identification of factor VIII B domain regions in hepatocyte cells.肝细胞中凝血因子VIII B结构域区域的功能鉴定
Biochem Biophys Res Commun. 2020 Jun 4;526(3):633-640. doi: 10.1016/j.bbrc.2020.03.132. Epub 2020 Apr 2.
10
Treatment Options in Hemophilia.血友病的治疗选择。
Dtsch Arztebl Int. 2019 Nov 22;116(47):791-798. doi: 10.3238/arztebl.2019.0791.